Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: RUA Life Sciences Reports Promising Elast-Eon Data

Mon, 23rd Nov 2020 18:03

RUA Life Sciences PLC - Ayrshire, Scotland-based medical device business - Notes findings from heart valve testing of Elast-Eon polymers. Says all valves tested "easily surpassed minimum ISO requirements" which means product can work on human hearts. Notes valves tested showed "remarkable consistency in performance". "The RUA surgical valve and Elast-Eon leaflet system have been designed to minimise stress with the objective of increasing the durability of heart valves," RUA says.

Current stock price: 150.00 pence

Year-to-date change: up 49%

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Rua Life Sci.

Shares in this article

Related News

RUA Life Sciences flags smaller EBITDA loss
22 May 2026

RUA Life Sciences flags smaller EBITDA loss

(Sharecast News) - RUA Life Sciences said in an update on Friday that it expected to report a smaller EBITDA loss, broadly reaching breakeven on an ad...

TRADING UPDATES: FIH sells assets; EnQuest reiterates guidance
22 May 2026

TRADING UPDATES: FIH sells assets; EnQuest reiterates guidance

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

TRADING UPDATES: Macfarlane extends long stop expiry for buyback
12 May 2026

TRADING UPDATES: Macfarlane extends long stop expiry for buyback

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: